Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

00017023182022-04-012022-09-300001702318us-gaap:PrivatePlacementMember2022-09-300001702318ahg:AmericanDepositoryMember2022-04-012022-09-300001702318ahg:AmericanDepositoryMember2018-12-102018-12-100001702318ahg:AmericanDepositoryMember2018-12-100001702318us-gaap:AdditionalPaidInCapitalMember2021-04-012021-09-300001702318us-gaap:CommonStockMember2021-04-012021-09-300001702318us-gaap:RetainedEarningsMember2022-09-300001702318us-gaap:NoncontrollingInterestMember2022-09-300001702318us-gaap:AdditionalPaidInCapitalMember2022-09-300001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001702318us-gaap:RetainedEarningsMember2022-03-310001702318us-gaap:NoncontrollingInterestMember2022-03-310001702318us-gaap:AdditionalPaidInCapitalMember2022-03-310001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001702318us-gaap:RetainedEarningsMember2021-09-300001702318us-gaap:AdditionalPaidInCapitalMember2021-09-300001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001702318us-gaap:RetainedEarningsMember2021-03-310001702318us-gaap:AdditionalPaidInCapitalMember2021-03-310001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-3100017023182018-07-232018-07-2300017023182018-07-222018-07-220001702318ahg:EquityIncentivePlan2016Member2018-03-312018-03-310001702318ahg:EquityIncentivePlan2016Member2016-04-012016-04-010001702318us-gaap:RestrictedStockUnitsRSUMember2022-09-3000017023182020-03-3100017023182019-03-3100017023182018-03-3100017023182018-04-012019-03-310001702318ahg:RevenueFromMedicalDevicesMember2022-04-012022-09-300001702318ahg:OnlineMarketplaceServicesAndOtherMember2022-04-012022-09-300001702318ahg:InterestMember2022-04-012022-09-300001702318ahg:RecommendationServiceRevenuesMember2021-04-012022-03-310001702318ahg:OnlineMarketplaceServicesAndOtherMember2021-04-012021-09-300001702318ahg:InterestMember2021-04-012021-09-300001702318ahg:RecommendationServiceRevenuesMember2020-04-012021-03-310001702318ahg:RecommendationServiceRevenuesMember2019-04-012020-03-310001702318srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Member2020-03-310001702318ahg:SosInformationTechnologyNewYorkIncMember2022-07-282022-07-280001702318srt:BoardOfDirectorsChairmanMember2021-07-012021-07-310001702318srt:BoardOfDirectorsChairmanMember2021-08-262021-08-260001702318srt:MinimumMemberus-gaap:OfficeEquipmentMember2022-04-012022-09-300001702318srt:MaximumMemberus-gaap:OfficeEquipmentMember2022-04-012022-09-300001702318us-gaap:OfficeEquipmentMember2022-09-300001702318us-gaap:OfficeEquipmentMember2022-03-310001702318us-gaap:RetainedEarningsMember2022-04-012022-09-300001702318us-gaap:RetainedEarningsMember2021-04-012021-09-300001702318us-gaap:PrivatePlacementMember2021-09-172021-09-1700017023182019-11-012019-11-300001702318us-gaap:NoncontrollingInterestMember2022-04-012022-09-300001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-09-300001702318us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-09-3000017023182021-10-152021-10-150001702318srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201602Member2019-04-010001702318us-gaap:NonUsMember2022-04-012022-09-300001702318us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-04-012022-09-300001702318us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-04-012021-09-300001702318ahg:WeHealthyLimitedMember2022-09-300001702318ahg:WeHealthLimitedMember2022-09-300001702318ahg:TianjinHaohongyuanTechnologyCo.LtdMember2022-09-300001702318ahg:QindaoAksoHealthManagementCo.LimitedMember2022-09-300001702318ahg:HxChinaInvestmentLimitedMember2022-09-300001702318ahg:HxAsiaInvestmentLimitedMember2022-09-300001702318ahg:HexinInvestmentPrivateLimitedMember2022-09-300001702318ahg:HexindaiHongKongLimitedMember2022-09-300001702318ahg:BeijingHexinYonghengTechnologyDevelopmentCo.LtdMember2022-09-300001702318ahg:AksoRemoteMedicalConsultationCenterIncMember2022-09-300001702318ahg:AksoOnlineMeditechCo.Ltd.Member2022-09-300001702318ahg:AksoFirstHealthTreatmentCenterIncMember2022-09-300001702318ahg:WeHealthyLimitedMemberahg:OtherInvestorsMember2022-09-300001702318ahg:WeHealthyLimitedMember2022-09-300001702318ahg:WeHealthyLimitedMember2022-03-3100017023182019-04-012019-04-010001702318ahg:IndividualsMember2022-04-012022-09-300001702318ahg:SosInformationTechnologyNewYorkIncMember2022-04-012022-09-300001702318ahg:WeHealthLimitedMembercountry:US2022-04-012022-09-300001702318ahg:AksoRemoteMedicalConsultationCenterIncMembercountry:US2022-04-012022-09-300001702318ahg:AksoOnlineMeditechCo.Ltd.Membercountry:US2022-04-012022-09-300001702318country:US2022-04-012022-09-300001702318country:CN2022-04-012022-09-300001702318us-gaap:CommercialLoanMemberahg:WebaoLtdMember2021-08-260001702318us-gaap:CommercialLoanMemberahg:WebaoLtdMember2021-03-310001702318srt:BoardOfDirectorsChairmanMember2021-03-310001702318us-gaap:DiscontinuedOperationsHeldforsaleMemberahg:HexinECommerceCompanyLimitedMember2020-12-160001702318ahg:OnlineMarketPlaceSegmentMember2022-04-012022-09-300001702318ahg:SosInformationTechnologyNewYorkIncMember2022-01-240001702318ahg:SosInformationTechnologyNewYorkIncMember2022-01-242022-01-240001702318us-gaap:CommercialLoanMemberahg:WebaoLtdMember2021-08-262021-08-260001702318ahg:HealthDevicesSegmentMember2022-04-012022-09-300001702318ahg:CustomerTwoMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerTwoMemberus-gaap:AccountsReceivableMemberus-gaap:CreditConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerThreeMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerOneMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerOneMemberus-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMember2022-04-012022-09-300001702318ahg:CustomerOneMemberus-gaap:AccountsReceivableMemberus-gaap:CreditConcentrationRiskMember2022-04-012022-09-300001702318us-gaap:TreasuryStockMember2022-09-300001702318us-gaap:CommonStockMember2022-09-300001702318us-gaap:TreasuryStockMember2022-03-310001702318us-gaap:CommonStockMember2022-03-310001702318us-gaap:TreasuryStockMember2021-09-300001702318us-gaap:CommonStockMember2021-09-300001702318us-gaap:TreasuryStockMember2021-03-310001702318us-gaap:CommonStockMember2021-03-310001702318ahg:EquityIncentivePlan2016Memberdei:AdrMember2018-07-232018-07-230001702318ahg:EquityIncentivePlan2016Member2018-07-232018-07-230001702318us-gaap:PrivatePlacementMember2021-08-090001702318currency:CNY2022-09-300001702318currency:CNY2022-03-310001702318ahg:OnlineMarketPlaceSegmentMember2022-09-300001702318ahg:HealthDevicesSegmentMember2022-09-300001702318ahg:OnlineMarketPlaceSegmentMember2021-03-310001702318ahg:HealthDevicesSegmentMember2021-03-3100017023182021-03-3100017023182020-08-2400017023182020-08-230001702318us-gaap:PrivatePlacementMember2022-04-012022-09-3000017023182020-08-242020-08-240001702318ahg:EquityIncentivePlan2016Member2022-09-300001702318ahg:EquityIncentivePlan2016Member2022-03-310001702318ahg:EquityIncentivePlan2016Member2018-03-3100017023182020-04-012021-03-3100017023182019-04-012020-03-310001702318ahg:EquityIncentivePlan2016Member2022-04-012022-09-300001702318ahg:EquityIncentivePlan2016Member2021-04-012022-03-310001702318ahg:EquityIncentivePlan2016Member2019-04-012020-03-310001702318ahg:EquityIncentivePlan2016Member2020-03-310001702318ahg:LeaseAgreementWithRelatedPartiesMembersrt:BoardOfDirectorsChairmanMember2020-10-152020-10-1500017023182022-05-222022-05-220001702318ahg:HighTechnologyEnterprisesMemberahg:HexinEDigitalCo.ltdMembercountry:CN2022-04-012022-09-3000017023182020-05-012020-05-310001702318us-gaap:CostOfGoodsTotalMemberus-gaap:SupplierConcentrationRiskMember2022-04-012022-09-300001702318us-gaap:DiscontinuedOperationsHeldforsaleMemberahg:HexinECommerceCompanyLimitedMember2021-07-142021-07-1400017023182021-07-132021-07-130001702318us-gaap:PrivatePlacementMember2021-08-092021-08-090001702318us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-09-300001702318us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CreditConcentrationRiskMember2022-04-012022-09-300001702318us-gaap:RestrictedStockUnitsRSUMember2021-04-012022-03-310001702318us-gaap:RestrictedStockUnitsRSUMember2018-04-012019-03-3100017023182021-04-012022-03-310001702318ahg:PhoenixIntelligentCreditGroupLtdMember2019-03-310001702318srt:MinimumMember2022-04-012022-09-300001702318srt:MaximumMember2022-04-012022-09-3000017023182021-09-300001702318ahg:PhoenixIntelligentCreditGroupLtdMember2019-01-080001702318ahg:MusketeerGroupInc.Member2018-08-090001702318ahg:PhoenixIntelligentCreditGroupLtdMember2022-09-300001702318ahg:MusketeerGroupInc.Member2022-09-300001702318ahg:PhoenixIntelligentCreditGroupLtdMember2022-03-310001702318ahg:MusketeerGroupInc.Member2022-03-3100017023182021-10-012022-03-310001702318ahg:SosInformationTechnologyNewYorkIncMember2022-07-272022-07-270001702318ahg:CommissionServicesMember2022-04-012022-09-300001702318ahg:CommissionServicesMember2021-04-012021-09-300001702318country:HK2022-09-300001702318ahg:OnlineMarketPlaceSegmentMember2021-04-012021-09-3000017023182020-05-310001702318us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-09-3000017023182022-09-300001702318us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-03-3100017023182022-03-3100017023182021-04-012021-09-30ahg:installmentahg:segmentiso4217:USDxbrli:purexbrli:sharesiso4217:USDxbrli:sharesiso4217:CNYiso4217:HKDahg:customerahg:loanahg:item

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of February 2023

Commission File Number: 001-38245

Akso Health Group

(Translation of registrant’s name into English)

Room 515, Floor 5, Jia No. 92-4 to 24 Jianguo Road

Chaoyang District, Beijing 100020

People’s Republic of China

Tel: [phone]

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

​	​
Form 20-F  ☒	Form 40-F  ☐

​

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

​

​

​

Interim Financial Statements

Akso Health Group (formerly known as Xiaobai Maimai Inc.) is furnishing this Form 6-K to provide six-month interim financial statements and incorporate such financial statements into the Company’s registration statements referenced below.

This Form 6-K is hereby incorporated by reference into the registration statements of the Company (the “Company”) on Form S-8 (Registration No. 333-223951) and on Form F-3s, as amended (Registration Nos. No. 333-250020 and 333-252434), to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

Financial Statements and Exhibits.

Exhibits.

​	​	​
Exhibit No.		Description
99.1	​	Unaudited Interim Consolidated Financial Statements as of September 30, 2022 and for the Six Months Ended September 30, 2022 and 2021
99.2	​	Operating and Financial Review and Prospects in Connection with the Unaudited Interim Consolidated Financial Statements for the Six Months Ended September 30, 2022 and 2021
101.INS	​	XBRL Instance Document
101.SCH	​	XBRL Taxonomy Extension Schema Document
101.CAL	​	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	​	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	​	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	​	XBRL Taxonomy Extension Presentation Linkbase Document
104	​	Cover Page Interactive Data File (embedded within the Inline XBRL document)

​

​

​

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

​		​	​	​
Dated:	February 16, 2023	Akso Health Group
​	​	​
​		By:	/s/ Yilin Wang
​		​	Name:	Yilin Wang
​		​	Title:	Chief Executive Officer

​

​